Impact (REF3a/b)

Impact template (REF3a)

Download template (66K)

All impact case studies

Download all case studies (699K)

Individual case studies

Aromatase inhibitors in breast cancer treatment (59K)

Developing and disseminating conformal radiotherapy and intensity modulated radiotherapy (132K)

Developing inhibitors of the PI3 kinase enzymes as novel therapeutics (66K)

Developing novel cancer therapeutics that inhibit the enzyme PKB (61K)

Development of abiraterone for the treatment of castration-resistant prostate cancer (62K)

Discovery of a new class of cancer drugs: HSP90 inhibitors (56K)

Identifying genes that increase the risk of developing cancer and exploiting these discoveries to enhance patient care and improve public health (155K)

Standardised radiotherapy dose fractionation for breast cancer treatment (197K)